I-Semaglutide ayisiyongxaki yokulahleka kwesisindo

I-Semaglutide sisiyobisi esisezantsi seglucose esiphuhliswe yi-novo rddisk sonyango lwesifo seswekile 2. NgoJuni 2021, i-FDA ivunyelwe i-semaglutide yokuthengisa njengechiza elilahlekileyo (igama lorhwebo le-wegovvy). Iyeza ichiza liyi-Glucagon-enje nge-golpide ye-Agonist enokuyilinganisa imiphumo, inciphise indlala, kwaye ke isebenza ngokutya, ke kuya kuba yimpumelelo ekunciphiseni ubunzima.

Ukongeza kokusetyenziswa ukunyanga uhlobo 2 lwesifo seswekile kunye nokutyeba, i-Semaglutide ifunyanwe ukukhusela impilo yentliziyo, inciphise umngcipheko womhlaza, kwaye uncede ekulahlekeni. Ukongeza, izifundo ezibini zakutshanje zibonise ukuba i-semaglutide inokunciphisa umngcipheko wesifo sezifo ezingapheliyo kunye nesifo se-Alzheimer's.

Izifundo zangaphambili zibonakalise ukuba ukunciphisa umzimba kunokunciphisa iimpawu ze-osteoarthritis (kubandakanya ukukhululeka kwepeyinti). Nangona kunjalo, iziphumo ze-GLP-1 ReadPtor Agnonist Colls Ilahleko Iziyobisi ezinjenge-semaglutide kwiziphumo ze-osteoartritis kwi-osteortiis kwizinto ezityebileyo azizange zifunde ngokupheleleyo.

Nge-30 ka-Okthobha, 2024, abaphandi beDyunivesithi yaseCopenhagen neNovo Ardusk bapapasha iPhepha loPhando kwi-Osnagricis eNgilane kwi-England Jouser of Porky

Olu phononongo lweklinikhi lubonise ukuba i-Semaglutide inokunciphisa kakhulu ubunzima kwaye inciphise kakhulu iintlungu ezinxulumene ne-arthritis enxulumene ne-edolo (i-analgesic ilingana ne-opioids), kwaye iphucule amandla abo okuthatha inxaxheba kwezemidlalo. Esi sihlandlo sokuqala ukuba luhlobo olutsha lweziyobisi zokunciphisa umzimba, i-Agonist ye-GLP-1 ye-GLP-1 ye-GLP-1 ye-GLP-1 ye-GLP-1 ye-GLP-1 ye-GLP-1 ye-GLP-1 ye-GLP-1 ye-GLP-1 ye-GLP-1 ye-GLP-1 ye-GLP-1 ye-GLP-1 ye-GLP-1 ye-GLP-1 iqinisekisiwe ukuba inyanga i-Artittis.